Survival Extrapolation in Cancer Immunotherapy: A Validation-Based Case Study

Ash Bullement has recently had an article published in Value in Health regarding the survival extrapolation techniques for patients treated with cancer immunotherapy.

The study considers a suite of candidate survival extrapolation methods that may be suitable, and concludes that those techniques that make use of external data appear to provide more accurate longer-term survival estimates.

You can read the article here